Skip to main content
. 2022 Aug 8;10(8):1916. doi: 10.3390/biomedicines10081916
TSH thyroid-stimulating hormone
WDTC well-differentiated thyroid cancer
AUS atypia of undetermined significance
FLUS follicular lesion of undetermined significance
ROM risk of malignancy
TBSRTC The Bethesda System for Reporting Thyroid Cytopathology
FDA Food and Drug Administration
TC thyroid cancer
UG-FNAB ultrasound-guided fine-needle aspiration biopsy
NIFTP noninvasive follicular neoplasms with papillary-like feature
SD standard deviation
PTC papillary thyroid cancer
FTC follicular thyroid cancer